UNCLASSIFIED
ARCHIVED Skip navigation.PDF Version     To Publications Page     To Home Page

Title:

Atlanta High Intensity Drug Trafficking Area Drug Market Analysis 2010

Publication Date: May 2010Cover image of Atlanta HIDTA Drug Market Analysis 2010.

Document ID: 2010-R0813-003

Archived on: September 1, 2011. This document may contain dated information. It remains available to provide access to historical materials.

This assessment is an outgrowth of a partnership between the NDIC and HIDTA Program for preparation of annual assessments depicting drug trafficking trends and developments in HIDTA Program areas. The report has been coordinated with the HIDTA, is limited in scope to HIDTA jurisdictional boundaries, and draws upon a wide variety of sources within those boundaries.

Your questions, comments, and suggestions for future subjects are welcome at any time. Addresses are provided at the end of the page.


Contents

Strategic Drug Threat Developments

HIDTA Overview

Drug Threat Overview

Drug Trafficking Organizations

Production

Transportation

Distribution

Drug-Related Crime

Abuse

Illicit Finance

Outlook

Appendix A - Tables

Sources


List of Figures

Figure 1. Atlanta High Intensity Drug Trafficking Area
Figure 2. Atlanta Metropolitan Area Transportation Infrastructure
Figure 3. North Carolina Counties in the Atlanta HIDTA Transportation Infrastructure

List of Tables

Table 1. Atlanta HIDTA Drug Seizures, by Initiative, in Kilograms, 2009
Table 2. Cannabis Plants Eradicated at Outdoor and Indoor Grow Sites in Georgia and North Carolina, 2005-2009
Table 3. Primary/Secondary/Tertiary Substance Problem at Admission, Atlanta HIDTA Counties in Georgia, State Fiscal Year (SFY) 2007-2009

Table A1. Methamphetamine Laboratories Seized in Atlanta HIDTA Counties, 2005-2009


Strategic Drug Threat Developments

The principal drug threats to the Atlanta High Intensity Drug Trafficking Area (HIDTA) region are the distribution and abuse of cocaine and the production and abuse of methamphetamine. Controlled prescription drugs (CPDs) pose an emerging threat and heroin remains a relatively low but growing threat to the region. In addition, the Atlanta area is the principal bulk cash consolidation center for Mexican drug trafficking organizations (DTOs) operating in the eastern United States.

The following are significant strategic drug threat developments in the Atlanta HIDTA region:

To Top      To Contents


Addresses

National Drug Intelligence Center
319 Washington Street, 5th Floor
Johnstown, PA 15901-1622

Tel. (814) 532-4601
FAX (814) 532-4690
E-mail NDIC.Contacts@usdoj.gov

 

Office of Policy and Interagency Affairs
U.S. Department of Justice
Robert F. Kennedy Building, Room 3341
950 Pennsylvania Avenue, NW
Washington, D.C. 20530-2000

Telephone: (202) 532-4040
FAX (202) 514-4252

Web Addresses

ADNET:  http://ndicosa.adnet.sgov.gov
DOJ:  http://www.justice.gov/archive/ndic/
LEO:  https://www.leo.gov/http/leowcs.leopriv.gov/lesig/archive/ndic/index.htm
RISS:  ndic.riss.net


Questions and comments may be directed to Southeast/Florida/Caribbean Unit, Regional Threat Analysis Branch through NDIC.Contacts@usdoj.gov.


Footnote

a. Opioid pain relievers include codeine, fentanyl (Duragesic, Actiq), hydromorphone (Dilaudid), meperidine (Demerol), morphine (MS Contin), oxycodone (OxyContin), methadone (Dolophine), and hydrocodone combinations (Vicodin, Lortab, and Lorcet).


To Top     To Contents     To Next Page

To Publications Page     To Home Page

UNCLASSIFIED


End of page.